Viewing Study NCT01092728


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-02-18 @ 12:03 AM
Study NCT ID: NCT01092728
Status: TERMINATED
Last Update Posted: 2016-09-05
First Post: 2010-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acral lentiginous melanoma View
None Mucosal melanoma View
None Chronic sun-damaged melanoma View
None Surgically removed tumor View
None biopsied View
None Sprycel View
None Dasatinib View